Pharmacokinetics and pharmacodynamic effects of ABT-627, an oral ETA selective endothelin antagonist, in humans

Benzer Materyaller

• Pharmacokinetics and pharmacodynamics of tezosentan, an intravenous dual endothelin receptor antagonist, following chronic infusion in healthy subjects
  Yazar:: Dingemanse, Jasper, ve diğerleri
  Baskı/Yayın Bilgisi: (2002)
• Organocatalytic Enantioselective Conjugate Addition of Nitromethane to Benzylidene-2-Benzoyl Acetate: Asymmetric Synthesis of ABT – 627, an Endothelin Receptor Antagonist
  Yazar:: Hajra, Saumen, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
  Yazar:: Sidharta, P. N., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Vasodilator effects of the endothelin ET(A) receptor selective antagonist BMS-193884 in healthy men
  Yazar:: Dhaun, Neeraj, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• Co-administration of ketoconazole with H(1)-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects
  Yazar:: Chaikin, P, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)